Dr. Ioannis Raftopoulos, MD

Dr. Raftopoulos practices at Holyoke Medical Center in Holyoke, Massachusetts, part of Valley Health Systems.

Dr. Raftopoulos' NPI, 1578538047, was assigned on February 20, 2006. Dr. Raftopoulos holds Massachusetts license 265321.

Dr. Raftopoulos' primary practice is Holyoke Medical Center, at 575 Beech Street, Holyoke, MA 01040 in Hampden County. The practice phone is (413) 534-2500.

Dr. Raftopoulos' primary practice is Holyoke Medical Center in Holyoke, Massachusetts, part of Valley Health Systems. The medical group on file is Holyoke Medical Center. Dmand AI also links Dr. Raftopoulos to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Raftopoulos' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raftopoulos practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Raftopoulos' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Raftopoulos' licenses on file in 2 states: Massachusetts and Connecticut.

CMS data shows 33 Medicare services from Dr. Raftopoulos across 2 procedure codes in 2024, for 37 Medicare patients. Medicare paid $2,836 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Raftopoulos in 2024. The largest group is under 65, with 18 patients. 73% of them have arthritis, and 73% have high cholesterol. 57% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Raftopoulos' median patient age at 43, with 79% women.

In 2024, Dr. Raftopoulos wrote 155 Medicare Part D claims for 48 patients. 90% of them were for generic drugs. CMS names the drug for 119 of them, across 3 drugs with 11 or more claims each, at $9,867 in total drug cost. In 2023, CMS named 101 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Raftopoulos for performance year 2024, reported through an alternative payment model (APM). Dr. Raftopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Raftopoulos as offering telehealth. CMS counts 19 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Raftopoulos, more than 49% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Raftopoulos, published from 2015 to 2020. 2016 was the busiest year, with 2. Dr. Raftopoulos' most frequent co-author is Ram Chuttani, MD.

Dmand AI links Dr. Raftopoulos to 1 clinical trial. Conditions studied include Obesity and Overnutrition.

CMS Open Payments shows 111 general payments to Dr. Raftopoulos from 8 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Heron Therapeutics, Inc. paid the most, $49,681.